SAM
IONS icon

Storebrand Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Storebrand Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-271
Closed -$17.7K – 794
2025
Q3 		$17.7K Hold
271
– – ﹤0.01% 786
2025
Q2 		$10.7K Hold
271
– – ﹤0.01% 792
2025
Q1 		$8.18K Hold
271
– – ﹤0.01% 813
2024
Q4 		$9.47K Hold
271
– – ﹤0.01% 813
2024
Q3 		$10.9K Hold
271
– – ﹤0.01% 848
2024
Q2 		$12.9K Hold
271
– – ﹤0.01% 844
2024
Q1 		$11.7K Hold
271
– – ﹤0.01% 850
2023
Q4 		$13.7K Hold
271
– – ﹤0.01% 848
2023
Q3 		$12.3K Hold
271
– – ﹤0.01% 851
2023
Q2 		$11.1K Sell
271
-11,370
-98% -$437K ﹤0.01% 850
2023
Q1 		$416K Sell
11,641
-1,421
-11% -$53.4K ﹤0.01% 732
2022
Q4 		$493K Hold
13,062
– – ﹤0.01% 714
2022
Q3 		$578K Sell
13,062
-9,400
-42% -$396K ﹤0.01% 701
2022
Q2 		$832K Hold
22,462
– – ﹤0.01% 689
2022
Q1 		$832K Hold
22,462
– – ﹤0.01% 692
2021
Q4 		$684K Sell
22,462
-12,204
-35% -$384K ﹤0.01% 728
2021
Q3 		$1.16M Sell
34,666
-756
-2% -$28.5K 0.01% 707
2021
Q2 		$1.41M Sell
35,422
-1,931
-5% -$75.6K 0.01% 685
2021
Q1 		$1.68M Hold
37,353
– – 0.01% 673
2020
Q4 		$2.11M Buy
37,353
+8,724
+30% +$435K 0.01% 624
2020
Q3 		$1.36M Hold
28,629
– – 0.01% 647
2020
Q2 		$1.69M Buy
28,629
+2,941
+11% +$164K 0.01% 608
2020
Q1 		$1.21M Buy
+25,688
New +$1.43M 0.01% 592

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Storebrand Asset Management's IONS Position: Q4 2025 in Review

Storebrand Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 271 shares — an estimated $17.7K sold.

Storebrand Asset Management first reported a position in IONS in Q1 2020 and held it in 23 quarters. The position peaked at $2.11M in Q4 2020. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

  • Storebrand Asset Management reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Storebrand Asset Management sold 271 Ionis Pharmaceuticals shares in Q4 2025, an estimated $17.7K.
  • Storebrand Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2020 and held it in 23 quarters.
  • Storebrand Asset Management's Ionis Pharmaceuticals position peaked at $2.11M in Q4 2020.
  • 491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on Storebrand Asset Management's 13F filing for Q4 2025, filed 20 May 2026.